Does ALIROCUMAB Cause Covid-19? 126 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Covid-19 have been filed in association with ALIROCUMAB (Praluent). This represents 0.6% of all adverse event reports for ALIROCUMAB.
126
Reports of Covid-19 with ALIROCUMAB
0.6%
of all ALIROCUMAB reports
8
Deaths
31
Hospitalizations
How Dangerous Is Covid-19 From ALIROCUMAB?
Of the 126 reports, 8 (6.3%) resulted in death, 31 (24.6%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Covid-19 Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 126 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Covid-19?
NIRMATRELVIR\RITONAVIR (22,066)
OCRELIZUMAB (11,454)
ADALIMUMAB (9,138)
DUPILUMAB (6,986)
RITUXIMAB (6,301)
LENALIDOMIDE (6,223)
TOFACITINIB (4,926)
SECUKINUMAB (3,871)
INFLIXIMAB (3,698)
TACROLIMUS (3,201)
Which ALIROCUMAB Alternatives Have Lower Covid-19 Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN